Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

Alvotech (NASDAQ:ALVO – Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $12.41, but opened at $12.80. Alvotech shares last traded at $12.87, with a ...

Key Insights Alvotech's significant private equity firms ownership suggests that the key decisions are influenced ...

The U.S. Food and Drug Administration (FDA) has accepted for review Biologics License Applications (BLA) for AVT05, ...

Has Alvotech (ALVO) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.

Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totalling 11,800 shares, a drop of 38.2% from the ...

In trading on Wednesday, shares of Alvotech (Symbol: ALVO) crossed below their 200 day moving average of $12.51, changing hands as low as $12.43 per share. Alvotech shares are currently trading ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the FDA has ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the U.S. FDA has ...